Jiangzhong Pharmaceutical Co Ltd (600750) — Capital Reinvestment Ratio
Jiangzhong Pharmaceutical Co Ltd (600750) has a Capital Reinvestment Ratio of 0.29x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥326.81 Million) in capital expenditures (CN¥95.46 Million). See 600750 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangzhong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Jiangzhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods. Check Jiangzhong Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangzhong Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Jiangzhong Pharmaceutical Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see 600750 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥970.87 Million | CN¥280.57 Million | ▼ -21.9% |
| 2024 | 0.37x | CN¥786.25 Million | CN¥290.77 Million | ▲ +83.4% |
| 2023 | 0.20x | CN¥1.04 Billion | CN¥208.88 Million | ▼ -40.4% |
| 2022 | 0.34x | CN¥1.02 Billion | CN¥345.64 Million | ▲ +64.6% |
| 2021 | 0.21x | CN¥917.04 Million | CN¥188.49 Million | ▼ -15.3% |
| 2020 | 0.24x | CN¥752.50 Million | CN¥182.53 Million | ▲ +103.8% |
| 2019 | 0.12x | CN¥641.18 Million | CN¥76.33 Million | ▼ -52.3% |
| 2018 | 0.25x | CN¥486.25 Million | CN¥121.38 Million | ▼ -82.8% |
| 2017 | 1.45x | CN¥124.93 Million | CN¥181.21 Million | ▲ +1345.1% |
| 2016 | 0.10x | CN¥698.05 Million | CN¥70.07 Million | ▼ -18.3% |
| 2015 | 0.12x | CN¥510.78 Million | CN¥62.75 Million | ▼ -57.2% |
| 2014 | 0.29x | CN¥356.80 Million | CN¥102.33 Million | ▼ -50.3% |
| 2013 | 0.58x | CN¥111.92 Million | CN¥64.59 Million | ▼ -41.8% |
| 2012 | 0.99x | CN¥226.38 Million | CN¥224.42 Million | ▼ -32.6% |
| 2011 | 1.47x | CN¥168.30 Million | CN¥247.55 Million | ▲ +132.1% |
| 2010 | 0.63x | CN¥222.29 Million | CN¥140.86 Million | ▲ +1138.0% |
| 2009 | 0.05x | CN¥378.32 Million | CN¥19.37 Million | ▼ -32.8% |
| 2008 | 0.08x | CN¥268.87 Million | CN¥20.49 Million | ▲ +4.9% |
| 2007 | 0.07x | CN¥153.63 Million | CN¥11.16 Million | ▼ -86.9% |
| 2006 | 0.56x | CN¥55.24 Million | CN¥30.69 Million | ▲ +68.5% |
| 2005 | 0.33x | CN¥198.45 Million | CN¥65.42 Million | ▼ -96.7% |
| 2004 | 10.01x | CN¥26.28 Million | CN¥263.03 Million | ▲ +241.5% |
| 2003 | 2.93x | CN¥78.98 Million | CN¥231.42 Million | ▲ +141.0% |
| 2002 | 1.22x | CN¥94.90 Million | CN¥115.40 Million | ▲ +892.2% |
| 2001 | 0.12x | CN¥41.28 Million | CN¥5.06 Million | ▼ -45.2% |
| 2000 | 0.22x | CN¥121.77 Million | CN¥27.22 Million | — |